NeuroSense Therapeutics Ltd. Adjustments For Increase Decrease In Trade Account Payable
NeuroSense Therapeutics Ltd. (NRSN) reported Adjustments For Increase Decrease In Trade Account Payable of $961.00 thousand for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable · last filed 2024-04-04
| Period end | Adjustments For Increase Decrease In Trade Account Payable 6 month | Adjustments For Increase Decrease In Trade Account Payable 12 month |
|---|---|---|
| 2023-12-31 | $961.00K 20-F · filed 2024-04-04 | |
| 2023-06-30 | $592.00K 6-K · filed 2023-08-16 | |
| 2022-12-31 | $459.00K 20-F · filed 2024-04-04 | |
| 2022-06-30 | $81.00K 6-K · filed 2023-08-16 | |
| 2021-12-31 | -$16.00K 20-F · filed 2024-04-04 | |
| 2021-06-30 | -$43.00K 6-K/A · filed 2023-01-19 | |
| 2020-12-31 | $32.00K 20-F · filed 2023-03-22 | |
| 2019-12-31 | $23.00K 20-F · filed 2022-04-14 |